Review of economic analyses of treatment for non-small-cell lung cancer (NSCLC)
{{output}}
Introduction: During the past few years, medical-economic evaluation of lung cancers (LCs) has become unavoidable. Total management costs have been rising constantly, with values almost doubling every 10 years. The financial impa... ...